SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001640334-23-000767 from Lexaria Bioscience Corp. (LEXX, LEXXW) (CIK 0001348362) (LEXX)

Lexaria Bioscience Corp. (LEXX, LEXXW) (CIK 0001348362)
Date: May 4, 2023 · CIK: 0001348362 · Accession: 0001640334-23-000767

AI Filing Summary & Sentiment

File numbers found in text: 333-271096

Date
May 4, 2023
Author
Not clearly detected
Form
CORRESP
Company
Lexaria Bioscience Corp. (LEXX, LEXXW) (CIK 0001348362)

Letter

mlfb_rw.htm

Lexaria Bioscience Corp.

100-740 McCurdy Road, Kelowna

British Columbia, Canada, V1X 2P7

May 4, 2023

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F. Street, N.E.

Washington, D.C. 20549

Attention: Tyler Howes

Re:

Lexaria Bioscience Corp

Registration Statement on Form S-1, as amended

Initially filed on April 3, 2023, as amended on April 28, 2023

File No. 333-271096 (the “Registration Statement”)

Withdrawal Request for Acceleration

Ladies and Gentlemen:

We hereby request the withdrawal of our request for acceleration, dated May 3, 2023, of the effective date of the Registration Statement on Form S-1, as amended (File No. 333-271096) that was requested to become effective at 9:00 a.m. Eastern Time, on May 5, 2023, or as soon thereafter as practicable. We hereby respectfully withdraw this acceleration request at this time.

Should any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel, Sichenzia Ross Ference LLP, attention: Avital Perlman, Esq. at (212) 930-9700.

Very truly yours,
LEXARIA BIOSCIENCE CORP

Show Raw Text
CORRESP
1
filename1.htm

mlfb_rw.htm

 Lexaria Bioscience Corp.

 100-740 McCurdy Road, Kelowna

 British Columbia, Canada, V1X 2P7

 May 4, 2023

 VIA EDGAR

 United States Securities and Exchange Commission

 Division of Corporation Finance

 Office of Life Sciences

 100 F. Street, N.E.

 Washington, D.C. 20549

 Attention: Tyler Howes

           Re:

   Lexaria Bioscience Corp

   Registration Statement on Form S-1, as amended

   Initially filed on April 3, 2023, as amended on April 28, 2023

   File No. 333-271096 (the “Registration Statement”)

   Withdrawal Request for Acceleration

 Ladies and Gentlemen:

 We hereby request the withdrawal of our request for acceleration, dated May 3, 2023, of the effective date of the Registration Statement on Form S-1, as amended (File No. 333-271096) that was requested to become effective at 9:00 a.m. Eastern Time, on May 5, 2023, or as soon thereafter as practicable. We hereby respectfully withdraw this acceleration request at this time.

 Should any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel, Sichenzia Ross Ference LLP, attention: Avital Perlman, Esq. at (212) 930-9700.

   Very truly yours,

   LEXARIA BIOSCIENCE CORP

     By:

   /s/ Christopher Bunka

   Christopher Bunka

   Chief Executive Officer